Market Cap | 1.95B | P/E | 10.47 | EPS this Y | 5.20% | Ern Qtrly Grth | -66.20% |
Income | 114.99M | Forward P/E | 9.90 | EPS next Y | 66.50% | 50D Avg Chg | -8.00% |
Sales | 656.11M | PEG | 0.79 | EPS past 5Y | 14.97% | 200D Avg Chg | -26.00% |
Dividend | N/A | Price/Book | 4.03 | EPS next 5Y | 22.60% | 52W High Chg | -48.00% |
Recommedations | 2.40 | Quick Ratio | 2.93 | Shares Outstanding | 56.83M | 52W Low Chg | 9.00% |
Insider Own | 19.75% | ROA | 13.75% | Shares Float | 34.68M | Beta | 0.73 |
Inst Own | 93.64% | ROE | 22.47% | Shares Shorted/Prior | 8.41M/8.73M | Price | 32.56 |
Gross Margin | 79.41% | Profit Margin | 17.53% | Avg. Volume | 465,361 | Target Price | 43.29 |
Oper. Margin | 12.36% | Earnings Date | Oct 29 | Volume | 863,927 | Change | -4.21% |
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.
Needham | Buy | Oct 2, 24 |
Needham | Buy | Sep 24, 24 |
Needham | Buy | Sep 12, 24 |
UBS | Buy | Sep 10, 24 |
Needham | Buy | Aug 8, 24 |
Needham | Buy | Aug 6, 24 |
Needham | Buy | Jun 25, 24 |
Needham | Buy | Jun 24, 24 |
Citigroup | Buy | Jun 21, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Nielsen Jack | Director Director | Dec 14 | Sell | 59.96 | 2,834 | 169,927 | 2,571,024 | 12/16/22 |
Wicki Andreas | Director Director | Dec 12 | Sell | 60.16 | 28,841 | 1,735,075 | 2,147,943 | 12/14/22 |
Nielsen Jack | Director Director | Dec 07 | Sell | 60.05 | 110,751 | 6,650,598 | 2,573,858 | 12/09/22 |
Nielsen Jack | Director Director | Dec 07 | Sell | 60.05 | 110,751 | 6,650,598 | 2,573,858 | 12/09/22 |
Wicki Andreas | Director Director | Dec 05 | Sell | 61.23 | 77,853 | 4,766,939 | 2,176,784 | 12/07/22 |
Nielsen Jack | Director Director | Nov 29 | Sell | 58.92 | 129,652 | 7,639,096 | 2,684,609 | 12/01/22 |
Nielsen Jack | Director Director | Nov 18 | Sell | 57.23 | 77,600 | 4,441,048 | 2,814,261 | 11/22/22 |
Wicki Andreas | Director Director | Nov 14 | Sell | 59.6 | 51,278 | 3,056,169 | 2,254,637 | 11/16/22 |
Nielsen Jack | Director Director | Nov 11 | Sell | 57.55 | 158,400 | 9,115,920 | 2,891,861 | 11/15/22 |
Wicki Andreas | Director Director | Nov 08 | Sell | 58.95 | 129,408 | 7,628,602 | 2,305,915 | 11/10/22 |
Wicki Andreas | Director Director | Nov 02 | Sell | 59.02 | 576,767 | 34,040,788 | 2,435,323 | 11/04/22 |
Dayno Jeffrey M. | CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER | Nov 01 | Option | 8.22 | 15,000 | 123,300 | 15,000 | 11/02/22 |
Dayno Jeffrey M. | CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER | Nov 01 | Sell | 55.1 | 15,000 | 826,500 | 11/02/22 | |
Wicki Andreas | Director Director | Aug 08 | Sell | 53.41 | 578,552 | 30,900,462 | 3,012,090 | 08/10/22 |
Nielsen Jack | Director Director | Aug 04 | Sell | 52.76 | 250,000 | 13,190,000 | 3,050,261 | 08/08/22 |
Wicki Andreas | Director Director | Aug 03 | Sell | 52.71 | 72,586 | 3,826,008 | 3,590,642 | 08/05/22 |
Nielsen Jack | Director Director | Jul 18 | Sell | 55.19 | 40,087 | 2,212,402 | 3,375,378 | 07/20/22 |
Nielsen Jack | Director Director | Jul 13 | Sell | 55.04 | 5,773 | 317,746 | 3,415,465 | 07/15/22 |
Nielsen Jack | Director Director | Jul 08 | Sell | 55.04 | 10,768 | 592,671 | 3,421,238 | 07/12/22 |
Nielsen Jack | Director Director | Jul 05 | Sell | 54.51 | 300,741 | 16,393,392 | 3,432,006 | 07/07/22 |
Nielsen Jack | Director Director | Jun 29 | Sell | 52.12 | 14,571 | 759,441 | 3,732,747 | 07/01/22 |
Nielsen Jack | Director Director | Jun 24 | Sell | 52.18 | 100,463 | 5,242,159 | 3,747,318 | 06/28/22 |
Nielsen Jack | Director Director | Apr 21 | Sell | 52.19 | 6,554 | 342,053 | 3,847,781 | 04/25/22 |
Nielsen Jack | Director Director | Apr 18 | Sell | 52.21 | 132,258 | 6,905,190 | 3,854,335 | 04/20/22 |
Nielsen Jack | Director Director | Apr 12 | Sell | 50.9 | 119,829 | 6,099,296 | 3,986,593 | 04/14/22 |
Nielsen Jack | Director Director | Apr 07 | Sell | 50.17 | 11,165 | 560,148 | 4,093,195 | 04/11/22 |
Nielsen Jack | Director Director | Apr 04 | Sell | 50.13 | 21,394 | 1,072,481 | 4,102,969 | 04/06/22 |
Dierks Jeffrey | Chief Commercial Off.. Chief Commercial Officer | Apr 01 | Option | 24 | 14,471 | 347,304 | 14,471 | 04/05/22 |
Dierks Jeffrey | Chief Commercial Off.. Chief Commercial Officer | Apr 01 | Sell | 49.61 | 14,471 | 717,906 | 04/05/22 | |
Nielsen Jack | Director Director | Mar 30 | Sell | 50.13 | 37,391 | 1,874,411 | 4,121,697 | 04/01/22 |
Nielsen Jack | Director Director | Mar 25 | Sell | 50.65 | 114,121 | 5,780,229 | 4,154,429 | 03/29/22 |
Nielsen Jack | Director Director | Mar 22 | Sell | 50.17 | 36,294 | 1,820,870 | 4,254,330 | 03/24/22 |
Nielsen Jack | Director Director | Mar 17 | Sell | 50.08 | 16,181 | 810,344 | 4,286,097 | 03/21/22 |
Jacobs John C | President, CEO President, CEO | Mar 16 | Option | 8.22 | 15,000 | 123,300 | 15,000 | 03/18/22 |
Jacobs John C | President, CEO President, CEO | Mar 16 | Sell | 45.32 | 15,000 | 679,800 | 03/18/22 | |
Wicki Andreas | Director Director | Mar 09 | Sell | 45.14 | 285,587 | 12,891,397 | 3,663,228 | 03/11/22 |
Wicki Andreas | Director Director | Mar 01 | Sell | 40.59 | 596,428 | 24,209,013 | 3,948,815 | 03/04/22 |
Dierks Jeffrey | Chief Commercial Off.. Chief Commercial Officer | Feb 16 | Option | 24 | 4,459 | 107,016 | 200 | 02/18/22 |
Dierks Jeffrey | Chief Commercial Off.. Chief Commercial Officer | Feb 16 | Sell | 40.03 | 8,518 | 340,976 | 02/18/22 | |
Wicki Andreas | Director Director | Dec 08 | Sell | 40.09 | 27,268 | 1,093,174 | 4,545,243 | 12/10/21 |
Dayno Jeffrey M. | Chief Medical Office.. Chief Medical Officer | Oct 19 | Option | 8.22 | 18,200 | 149,604 | 4,101 | 10/20/21 |
Dayno Jeffrey M. | Chief Medical Office.. Chief Medical Officer | Oct 19 | Sell | 43.45 | 18,200 | 790,790 | 10/20/21 | |
Dierks Jeffrey | Chief Commercial Off.. Chief Commercial Officer | Sep 09 | Sell | 37 | 5,000 | 185,000 | 09/09/21 | |
Dierks Jeffrey | Chief Commercial Off.. Chief Commercial Officer | Sep 09 | Option | 8.22 | 5,000 | 41,100 | 5,000 | 09/09/21 |
Dayno Jeffrey M. | Chief Medical Office.. Chief Medical Officer | Sep 09 | Sell | 37.58 | 10,000 | 375,800 | 09/09/21 | |
Dayno Jeffrey M. | Chief Medical Office.. Chief Medical Officer | Sep 09 | Option | 8.22 | 10,000 | 82,200 | 10,000 | 09/09/21 |